Sign Up
av/peak-bio--big.svg

COM:PEAK-BIO

Peak Bio, Inc.

  • Stock

USD

Last Close

0.05

14/11 20:00

Market Cap

192.60K

Beta: -

Volume Today

1.93K

Avg: -

OverviewAnalysisMetricsFinancialsFilingsAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
average inventory
-1.29T
-
average payables
1.96M
-
4.74M
141.88%
average receivables
160.08K
-
book value per share
-0.11
-
-0.46
305.29%
-0.61
34.48%
capex per share
-0.00
-
-0.01
1,295.13%
capex to depreciation
-0.06
-
-0.18
223.38%
capex to operating cash flow
0.00
-
0.02
1,604.92%
capex to revenue
-0.02
-
-0.23
1,151.71%
cash per share
0.01
-
0.04
208.84%
0.01
65.06%
days of inventory on hand
days payables outstanding
-0.00
-
19.98M
919,362,672,866.14%
days sales outstanding
74.60
-
debt to assets
0.74
-
4.13
454.99%
debt to equity
-0.69
-
-0.59
14.68%
dividend yield
earnings yield
-0.05
-
-0.18
255.53%
-0.00
99.87%
enterprise value
166.96M
-
79.16M
52.59%
15.88M
79.94%
enterprise value over ebitda
-18.78
-
-6.66
64.52%
-11.71K
175,592.30%
ev to operating cash flow
-18.84
-
-10.57
43.86%
-3.34
68.44%
ev to sales
316.03
-
130.27
58.78%
43.17
66.86%
free cash flow per share
-0.52
-
-0.43
16.71%
-0.16
62.60%
free cash flow yield
-0.05
-
-0.10
93.62%
-0.86
735.68%
graham net net
-0.16
-
-0.85
416.56%
-0.69
18.64%
graham number
1.11
-
2.76
148.97%
0.02
99.12%
income quality
1.07
-
0.57
46.50%
0.37
35.14%
intangibles to total assets
0
-
0
0
interest coverage
-790.30
-
-247.05
68.74%
interest debt per share
0.00
-
0.32
47,631.89%
0.36
13.76%
inventory turnover
invested capital
-0.69
-
-18.00M
2,599,964,822.34%
market cap
167.17M
-
74.21M
55.61%
5.54M
92.54%
net current asset value
-2.55M
-
-12.39M
385.18%
-18.38M
48.30%
net debt to ebitda
0.02
-
-0.42
1,901.86%
-7.62K
1,830,316.82%
net income per share
-0.48
-
-0.74
52.94%
-0.00
99.99%
operating cash flow per share
-0.52
-
-0.42
18.17%
-0.16
61.89%
payables turnover
-167.96K
-
0.00
100.00%
receivables turnover
4.89
-
research and ddevelopement to revenue
13.48
-
6.46
52.11%
return on tangible assets
-7.69
-
-1.74
77.40%
-0.00
99.97%
revenue per share
0.03
-
0.03
11.46%
0.01
63.71%
roe
4.28
-
1.62
62.26%
0.00
100.00%
roic
4.73
-
-6.79
243.45%
0.00
100.00%
sales general and administrative to revenue
4.67
-
14.04
200.31%
0.00
100.00%
shareholders equity per share
-0.11
-
-0.46
305.29%
-0.61
34.48%
stock based compensation to revenue
0.01
-
0.92
9,857.22%
0.75
18.77%
tangible asset value
-1.94M
-
-8.09M
318.26%
-18.16M
124.31%
tangible book value per share
-0.11
-
-0.46
305.29%
-0.61
34.48%
working capital
-2.33M
-
-7.57M
224.52%
-18.15M
139.73%

All numbers in USD (except ratios and percentages)